histologically diagnosed with Stage II-III HER2+ breast cancer (primary diameter \>2cm)
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
Intact renal, hepatic, bone marrow and cardiac functions including baseline left ventricular ejection fraction (LVEF) ≥ 55% measured by echocardiography
No prior treatment
You may not be if
Bilateral or metastatic breast cancer
History of other malignancies
Severe cardiovascular disease
Allergic to any of the regimens
Clareo Health | ctDNA in HER2+ EBC Neoadjuvant Treatment
